Author

D. Schrimpf

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

D. E. Reuss· 2 shared D. Stichel· 2 shared D. Sturm· 2 shared G. Reifenberger· 2 shared L. Krskova· 2 shared M. Sill· 2 shared M. Snuderl· 2 shared N. Jabado· 2 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. E. Reuss

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial ependymoma

P. Sievers, S. C. Henneken, C. Blume, M. Sill, D. Schrimpf, D. Stichel, K. Okonechnikov, D. E. Reuss, J. Benzel, K. Maass, M. Kool, D. Sturm, P. Kohlhof-Meinecke, O. Cruz, M. Mariona Sunol, , Z

The paper identifies a novel subset of supratentorial ependymomas in children characterized by recurrent PLAGL1 fusions and distinct molecular features.

bioRxiv · Apr 23, 2021 · PreprintCancer Biology

A subset of pediatric thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR

P. Sievers, M. Sill, D. Schrimpf, D. Stichel, D. E. Reuss, D. Sturm, J. Hench, S. Frank, L. Krskova, A. Vicha, M. Zapotocky, B. Bison, P. N. Harter, M. Snuderl, C. M. Kramm, , F. Sahm

This study identifies a distinct subset of pediatric gliomas with EGFR alterations, H3K27me3 loss, and broad tumor localization, suggesting EGFR inhibition as a potential therapy.

bioRxiv · Aug 28, 2020Cancer Biology